Lifesemantics

LifeSemantics Corp. is a South Korean digital healthcare company founded in 2012 that built LifeRecord, described as the first commercial PHR (personal health record) based data platform in Korea. The platform integrates health record data dispersed across hospitals, government bodies and corporations into a personalized health management service, and applies disease occurrence and prognosis prediction algorithms to estimate the probability of conditions such as cancer and stroke. Reported analytical use cases include prediction of breast cancer recurrence, pneumonia and cardiovascular disease, together with recommendations for treatment and nutritional plans, supporting self-management programs and pre-emptive care for both individuals and healthcare service providers.

The company trades on the KOSDAQ exchange under code A347700 and has since been renamed Sphere Corp. Under that name the business is described as principally engaged in the digital healthcare platform business, developing and providing digital healthcare services and solutions, developing and manufacturing health functional food raw materials, developing and supplying AI medical devices, and supplying special alloys for the aerospace industry. It has operated subsidiaries including NutraSemantics and Nexus Bridge, and in December 2024 agreed to acquire the remaining 99% stake in Sphere Korea Inc.

The corporate website presents the group under the SphereCorp. brand as a "lifecare" company positioned beyond healthcare, stating an aim to make health and lifecare products and services usable and directly purchasable by consumers. The company frames four problems it seeks to address: the difficulty of understanding specialized medical information, service delivery designed around providers rather than users, regulation that restricts access to healthcare technology, and affordability. It also markets a Korean Standard Classification of Diseases (KCD) code and disease-name search tool, and a product line referred to as Clarius.

Business model

The company develops and supplies digital healthcare platforms and solutions, notably the LifeRecord PHR data platform, serving both healthcare service providers and individual users. It has pursued collaboration models with adjacent industries such as insurance, finance, food and fitness to deliver a broader health management offering, and states an intent to sell lifecare products and services that consumers can purchase directly. Related business lines under the Sphere Corp. name include health functional food raw materials, AI medical devices and special alloys for aerospace.

Traction

Reported milestones include commercialization of the LifeRecord PHR platform, a 2018 strategic investment from CareLabs for an 18.4% stake, KOSDAQ listing, international pilots in Thailand and outreach in Paraguay, pursuit of clinical trials and regulatory approvals for its products, and expansion through subsidiaries NutraSemantics and Nexus Bridge.

Latest developments

In December 2024 LifeSemantics Corp. agreed to acquire the remaining 99% stake in Sphere Korea Inc. from Gwang-soo Choi, Choi Nebula and Taekyung Kim for KRW 61.9 billion, issuing 16.5 million shares at an exchange ratio of 1:164.6090535; upon completion it would hold 100% of Sphere Korea Inc., which reported total assets of KRW 30.68 billion as of September 30, 2024. The transaction was reported as completed in 2025. The listed entity now operates as Sphere Corp., with activities spanning digital healthcare, health functional food raw materials, AI medical devices and aerospace special alloys.